推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CRIT REV ONCOL 最新评论:请问现在有消息了吗 (2024-02-25)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY期刊基本信息Hello,您是该期刊的第30397位访客

基本信息 登录收藏
期刊名字CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

CRIT REV ONCOL HEMAT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.5
51人评分
我要评分

声誉
8.7

影响力
6.7

速度
6.9

期刊ISSN1040-8428
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
6.2 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:5.371
2022-2023自引率3.20%点击查看自引率趋势图
五年影响因子6.2
h-index 111
CiteScore
CiteScoreSJRSNIPCiteScore排名
10.501.5101.475
学科分区排名百分位
大类:Medicine
小类:Geriatrics and Gerontology
Q15 / 107
大类:Medicine
小类:Oncology
Q144 / 366
大类:Medicine
小类:Hematology
Q116 / 129

期刊简介
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
期刊官方网站http://www.croh-online.com/
期刊投稿网址http://ees.elsevier.com/croh
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY的语言要求,还能让CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
出版商Elsevier Ireland Ltd
涉及的研究方向医学-血液学
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份1983
年文章数 213点击查看年文章数趋势图
Gold OA文章占比12.91%
研究类文章占比:
文章 ÷(文章 + 综述)
0.00%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:HEMATOLOGY
类别:SCIE
Q119/79
学科:ONCOLOGY
类别:SCIE
Q154/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区2区4区
HEMATOLOGY
血液学
1区2区2区
ONCOLOGY
肿瘤学
3区3区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区2区
HEMATOLOGY
血液学
2区3区2区
ONCOLOGY
肿瘤学
3区1区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区4区
HEMATOLOGY
血液学
4区3区2区
ONCOLOGY
肿瘤学
1区1区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D
平均审稿速度网友分享经验:
偏慢,4-8周
来源Elsevier官网:
平均27.3周
平均录用比例网友分享经验:
一般
来源Elsevier官网:
83%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
在线出版周期来源Elsevier官网:
平均8.8周
期刊常用信息链接
同领域相关期刊 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal of Hematology & Oncology6038.40
    BLOOD42621.90
    AMERICAN JOURNAL OF HEMATOLOGY9215.10
    LEUKEMIA17617.10
    HAEMATOLOGICA12513.30
    BLOOD REVIEWS8516.40
    BRITISH JOURNAL OF HAEMATOLOGY1727.90
    TRANSFUSION MEDICINE REVIEWS6511.40
    HAEMOPHILIA845.70
    SEMINARS IN HEMATOLOGY886.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE604423
    BIOMATERIALS516013
    BIOMEDICINE & PHARMACOTHERAPY467203
    Journal of Materials Chemistry B461458
    Frontiers in Pharmacology452425
    Frontiers in Immunology424037
    JOURNAL OF ETHNOPHARMACOLOGY407684
    COLLOIDS AND SURFACES B-BIOINTERFACES405430
    Frontiers in Oncology385987
    Acta Biomaterialia377594
  •  

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Rare histotypes of epithelial biliary tract tumors: A literature review

    Author: Sapuppo, Elena; Brunetti, Oronzo; Tessitore, Dalila; Brandi, Giovanni; Di Giovanni, Nicola; Fadda, Guido; Luchini, Claudio; Martini, Maurizio; Quaresmini, Davide; Russo, Antonio; Santarpia, Mariacarmela; Scarpa, Aldo; Scartozzi, Mario; Tuccari, Giovanni; Franchina, Tindara; Silvestris, Nicola
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103892
        PubMed      DOI
    2.Changing patterns of neoadjuvant therapy for locally advanced rectal cancer: A narrative review

    Author: He, Weijing; Li, Qingguo; Li, Xinxiang
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103885
        PubMed      DOI
    3.The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis

    Author: Liu, Hao; Li, Zhuoqun; Han, Xuan; Li, Zhujun; Zhao, Yan; Liu, Fenghua; Zhu, Ziyu; Lv, Yi; Liu, Zhijun; Zhang, Nana
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103893
        PubMed      DOI
    4.HER2-low breast cancer: Novel detections and treatment advances

    Author: Wu, Yun; Zhong, Ruiqi; Ma, Fei
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103883
        PubMed      DOI
    5.Exosomes in sarcoma: Prospects for clinical applications

    Author: Ye, Huali; Tan, Linyun; Tu, Chongqi; Min, Li
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 181, Issue , pp. -. DOI: 10.1016/j.critrevonc.2022.103895
        PubMed      DOI
    6.NTRK fusions in thyroid cancer: Pathology and clinical aspects

    Author: Ma, Yanhui; Zhang, Qi; Zhang, Kexin; Liang, Yunzi; Ren, Fangbing; Zhang, Jingwen; Kan, Chengxia; Han, Fang; Sun, Xiaodong
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2023; Vol. 184, Issue , pp. -. DOI: 10.1016/j.critrevonc.2023.103957
        PubMed      DOI
    7.Impact of age on the overall survival benefits of anti-EGFR-containing regimens in head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials

    Author: Yuguang Zhao, Wenhui Liu, Meiting Sun, Qiuli Miao, Yingmin Liu, Huimin Tian, Yapin Su, Fujun Han
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 39-46, DOI:10.1016/j.critrevonc.2019.01.017
        DOI
    8.The roles of EBV-encoded microRNAs in EBV-associated tumors

    Author: Min Dong, Jian-ning Chen, Jun-ting Huang, Li-ping Gong, Chun-kui Shao
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 30-38, DOI:10.1016/j.critrevonc.2019.01.014
        DOI
    9.Corrigendum to “Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy” [Crit. Rev. Oncol./Hematol. 128 (August) (2018) 110–117]

    Author: Bin Zhao, Hong Zhao, Jiaxin Zhao
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 20, DOI:10.1016/j.critrevonc.2019.01.007
        DOI
    10.Combination versus mono-therapy as second-line treatment for advanced biliary tract cancer: a systematic review and meta-analysis of published data

    Author: Jie Ying, Jinfei Chen
    Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol., , DOI:10.1016/j.critrevonc.2019.01.001
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共67条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451